Metabolomics: The Next Omics Technology for the Diagnostics IndustryDecision ResourcesSeptember 21, 2005 13 Pages - SKU: DECR1212123 |
| Metabolomics, the study of the small-molecule metabolites produced by the body, has recently been added to the expanding toolbox of useful "omics" technologies: genomics, transcriptomics, and proteomics, all of which are being used in basic research, drug discovery and development, and in vitro diagnostics as biomarkers of disease. The information garnered through metabolomics will lead to the development of novel diagnostic tools to assist in the identification of disease conditions; it will also be implemented in the drug development process, as the effected metabolic pathways may be utilized as viable drug targets in the treatment of disease. This report highlights the opportunities that metabolomics offers for new in vitro diagnostic tests and provides a brief review of the technology behind the field, examples of ongoing metabolomics research, and descriptions of select companies active in this field. Please note: the PDF e-mail from publisher version of this report is for a global site license. |
Related Markets
- Biotechnology
- Genomics
- Informatics
- Proteomics
- In Vitro Diagnostics
- General In Vitro Diagnostics
- Pharmaceuticals
- Drug Discovery
Drug Discovery Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012
- Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012
- Restless Legs Syndrome Global Clinical Trials Review, H1, 2012
- Lung Injury Global Clinical Trials Review, H1, 2012
